Multimodal surgical site injection has no clinical benefit versus control in ankle fracture fixation .
Efficacy of Multimodal Analgesic Injections in Operatively Treated Ankle Fractures: A Randomized Controlled Trial
J Bone Joint Surg Am.2019;101(24):2194-2202.Patients undergoing fracture fixation are at risk for experiencing severe pain and requiring opioids. Given the ongoing opioid crisis, any intervention that can reduce the reliance in opioids is of interest. The authors of this study randomized 100 patients undergoing surgical management of isolated, closed ankle fractures to receive a multimodal surgical site injection or no injection (control). They found that while the injection reduced pain in a statistically significant manner up to 48 hours, it had no impact on opioid use, length of stay, or discharge destination. As well, the improvement in pain scores did not reach clinical significance.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
